Evidence map›Paper›PMID 33759129›Full record

ReviewMethods in molecular biology (Clifton, N.J.)2021

Free Energy Calculations for Protein-Ligand Binding Prediction.

Willem Jespers, Johan Åqvist, Hugo Gutiérrez-de-Terán

Abstract readReview
PubMed Publisher
In one paragraph

Review in Methods in molecular biology (Clifton, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. The structural basis of aldo-keto reductase 1C3 inhibition by 17α-picolyl and 17(Journal of enzyme inhibition and medicinal chemistry · 2025
    Article
  3. The physics-AI dialogue in drug design.RSC medicinal chemistry · 2025
    Review
  4. Article
  5. Multi-target therapeutic potential of Neem (In silico pharmacology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Introducing the Automated Ligand Searcher.Journal of chemical information and modeling · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Willem JespersDepartment of Cell and Molecular Biology, Biomedical Center, Uppsala University, Uppsala, Sweden.
Johan ÅqvistDepartment of Cell and Molecular Biology, Biomedical Center, Uppsala University, Uppsala, Sweden.
Hugo Gutiérrez-de-TeránDepartment of Cell and Molecular Biology, Biomedical Center, Uppsala University, Uppsala, Sweden. hugo.gutierrez@icm.uu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computational prediction of protein-ligand binding involves initial determination of the binding mode and subsequent evaluation of the strength of the protein-ligand interactions, which directly correlates with ligand binding affinities. As a consequence of increasing computer power, rigorous approaches to calculate protein-ligand binding affinities, such as free energy perturbation (FEP) methods, are becoming an essential part of the toolbox of computer-aided drug design. In this chapter, we provide a general overview of these methods and introduce the QFEP modules, which are open-source API workflows based on our molecular dynamics (MD) package Q. The module QligFEP allows estimation of relative binding affinities along ligand series, while QresFEP is a module to estimate binding affinity shifts caused by single-point mutations of the protein. We herein provide guidelines for the use of each of these modules based on data extracted from ligand-design projects. While these modules are stand-alone, the combined use of the two workflows in a drug-design project yields complementary perspectives of the ligand binding problem, providing two sides of the same coin. The selected case studies illustrate how to use QFEP to approach the two key questions associated with ligand binding prediction: identifying the most favorable binding mode from different alternatives and establishing structure-affinity relationships that allow the rational optimization of hit compounds.

Indexed as

Molecular Dynamics SimulationAlgorithmsComputer-Aided DesignDrug DesignDrug DiscoveryIn Vitro TechniquesLigandsMutagenesis, Site-DirectedMutationProtein BindingProteinsQuantitative Structure-Activity RelationshipThermodynamicsWorkflowLigandsProteinsBinding free energyFree energy perturbation (FEP)Molecular dynamics (MD)Structure-based drug design (SBDD)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.